Get a glimpse into our company and investor data—powered by the PitchBook Platform
A monoclonal antibody fragment. The asset is used for the treatment and prevention of ovarian carcinoma.
This information is reserved for PitchBook Platform users. To explore FabOvar‘s full profile, request access.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.